41
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Artesunate (ART) has been used for a long time in the treatment of Plasmodium falciparum malaria and has been considered safe. The present phase I study aimed to determine the daily dose of ART that is well tolerated as add-on therapy in patients with breast cancer for 4 weeks of therapy. Ototoxicity could be a potential safety concern in settings different from malaria. Therefore, comprehensive audiological assessment was essential.

          Related collections

          Author and article information

          Journal
          Cancer Chemother. Pharmacol.
          Cancer chemotherapy and pharmacology
          1432-0843
          0344-5704
          Feb 2016
          : 77
          : 2
          Affiliations
          [1 ] Department of Otolaryngology, Head and Neck Surgery, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
          [2 ] Naturopathy and Integrative Medicine, Department of Gynecological Endocrinology and Reproductive Medicine, University Women's Hospital, Heidelberg, Germany.
          [3 ] Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital, Heidelberg, Germany.
          [4 ] Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
          [5 ] Department of Otolaryngology, Head and Neck Surgery, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. serkan.sertel@med.uni-heidelberg.de.
          Article
          10.1007/s00280-016-2960-7
          10.1007/s00280-016-2960-7
          26793976
          4ed3fe54-6dfb-463b-bc4e-c1aeab759afa
          History

          Artesunate,Breast cancer,Metastasis,Ototoxicity
          Artesunate, Breast cancer, Metastasis, Ototoxicity

          Comments

          Comment on this article